Valuation: Camlin Fine Sciences Limited

Market Cap 18.23B 189M 168M 157M 143M 269M 271M 1.89B 734M 9.3B 710M 695M 29.93B P/E 2027 *
23.7x
P/E 2028 * 11.6x
Enterprise Value 18.23B 189M 168M 157M 143M 269M 271M 1.89B 734M 9.3B 710M 695M 29.93B EV / Sales 2027 *
0.85x
EV / Sales 2028 * 0.77x
Free-Float
55.75%
Yield 2027 *
-
Yield 2028 * -
1 day+4.02%
1 week-0.62%
Current month+2.00%
1 month-7.94%
3 months-30.57%
6 months-8.04%
Current year-36.02%
1 week 89.4
Extreme 89.4
95.74
1 month 89.4
Extreme 89.4
106.4
Current year 89.4
Extreme 89.4
192
1 year 89.4
Extreme 89.4
211.4
3 years 80
Extreme 80
334.7
5 years 80
Extreme 80
334.7
10 years 33.4
Extreme 33.4
334.7
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Executive Officer 60 31/05/2021
Director of Finance/CFO - 17/08/2026
Director TitleAgeSince
Director/Board Member 60 03/08/2014
Chairman 63 16/06/2021
Director/Board Member 60 12/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/24
Infinity Holdings
SellCompany 1,338,600 0.7992%
09/09/24
Infinity Holdings
SellCompany 663,586 0.3962%
Change 5-day change 1-year change 3-year change Capi.($)
+4.02%-0.62%-50.94%-42.58% 182M
+1.35%+0.21%+1.53%+66.72% 77.67B
+0.62%-0.47%+4.87%+17.15% 37.55B
+0.29%-5.44%-2.82%-23.86% 33.78B
+2.32%-1.05%+5.28%+7.32% 30.89B
+1.17%+1.10%+10.20%+48.31% 29.78B
+0.59%+2.06%-5.62%+21.15% 25.76B
+0.42%+1.09%+46.20%+37.10% 23.46B
+0.52%+1.55%+53.49%+24.68% 18.8B
+1.98%+1.76%-44.27%-39.68% 17.65B
Average +1.33%-1.74%+1.79%+11.63% 29.55B
Weighted average by Cap. +1.07%-1.50%+6.18%+26.58%

Financials

2027 *2028 *
Net sales 21.33B 221M 197M 184M 167M 315M 317M 2.21B 859M 10.88B 831M 813M 35.01B 23.62B 245M 218M 204M 185M 348M 351M 2.45B 951M 12.05B 920M 900M 38.77B
Net income 765M 7.94M 7.05M 6.6M 5.98M 11.28M 11.37M 79.25M 30.8M 390M 29.8M 29.16M 1.26B 1.57B 16.27M 14.45M 13.52M 12.25M 23.11M 23.3M 162M 63.12M 800M 61.06M 59.75M 2.57B
Net Debt - -
Projected Income Statement - Annual - Camlin Fine Sciences Limited
Logo Camlin Fine Sciences Limited
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Employees
674
Date Price Change Volume
06/10/26 ₹94.91 +4.02% 84,718
05/10/26 ₹91.24 +0.12% 22,193
01/10/26 ₹91.13 -2.06% 36,387
30/09/26 ₹93.05 -0.21% 23,651
29/09/26 ₹93.25 -2.36% 77,373
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Camlin Fine Sciences Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
94.91INR
Average target price
152.50INR
Spread / Average Target
+60.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camlin Fine Sciences Limited
  1. Stock Market
  2. Stocks
  3. CAMLINFINE Stock